PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

PET Scan as a Screening Tool for Liver Transplant in Patients With HCC

This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.

Inclusion Criteria:

• Male or female patient over 18 years of age
• Diagnosis of HCC confirmed by histology if available or by two imaging modalities
• Able to give written informed consent prior to any study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.

Exclusion Criteria:

• Unable to give consent to the study
• Unable to undergo a PET Scan